We are live on ! Find out more
CCM

Cinctive Capital Management Portfolio holdings

AUM $1.53B
1-Year Est. Return 48.83%
This Fund
S&P 500
This Quarter Est. Return
+7.18%
1 Year Est. Return
+48.83%
3 Year Est. Return
+143.95%
5 Year Est. Return
+199.46%
10 Year Est. Return
AUM
$1.97B
AUM Growth
+$131M
Cap. Flow
+$90.9M
Cap. Flow %
4.63%
Top 10 Hldgs %
17.59%
Holding
518
New
156
Increased
91
Reduced
88
Closed
176

Sector Composition

Rank Sector Weight
1 Healthcare 17.37%
2 Financials 14.81%
3 Consumer Discretionary 12.67%
4 Technology 11.04%
5 Utilities 9.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALTM
226
DELISTED
Arcadium Lithium plc
ALTM
$1.85M 0.09%
+360,000
New +$1.84M
CDMO
227
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$1.83M 0.09%
147,818
-154,833
-51% -$1.77M
AIT icon
228
Applied Industrial Technologies
AIT
$12.8B
$1.82M 0.09%
7,609
+5,640
+286% +$1.41M
STVN icon
229
Stevanato
STVN
$5.42B
$1.81M 0.09%
83,156
+58,792
+241% +$1.18M
AXTA icon
230
Axalta
AXTA
$7.66B
$1.79M 0.09%
52,436
+27,714
+112% +$1.04M
BHC icon
231
Bausch Health
BHC
$2.58B
$1.79M 0.09%
222,348
+138,638
+166% +$1.14M
PNW icon
232
Pinnacle West Capital
PNW
$12.2B
$1.79M 0.09%
+21,107
New +$1.87M
BLCO icon
233
Bausch + Lomb
BLCO
$6.04B
$1.75M 0.09%
96,696
+51,594
+114% +$1.01M
CRS icon
234
Carpenter Technology
CRS
$25.8B
$1.75M 0.09%
10,283
-17,188
-63% -$2.95M
INSM icon
235
Insmed
INSM
$21.4B
$1.74M 0.09%
25,252
-5,454
-18% -$393K
BNTX icon
236
BioNTech
BNTX
$22.9B
$1.68M 0.09%
+14,760
New +$1.68M
MDGL icon
237
Madrigal Pharmaceuticals
MDGL
$10.8B
$1.67M 0.08%
5,406
+332
+7% +$93.4K
HLT icon
238
Hilton Worldwide
HLT
$72.1B
$1.65M 0.08%
+6,657
New +$1.63M
IDXX icon
239
Idexx Laboratories
IDXX
$44.1B
$1.63M 0.08%
3,942
+622
+19% +$273K
GTES icon
240
Gates Industrial Corporation Ltd.
GTES
$7.08B
$1.63M 0.08%
+79,143
New +$1.6M
BEAM icon
241
Beam Therapeutics
BEAM
$2.63B
$1.62M 0.08%
+65,242
New +$1.67M
FWRD icon
242
CALL
Forward Air
FWRD
$444M
$1.61M 0.08%
50,000
AVTR icon
243
Avantor
AVTR
$9.32B
$1.59M 0.08%
75,330
-83,912
-53% -$1.89M
NSC icon
244
Norfolk Southern
NSC
$75.4B
$1.58M 0.08%
6,747
-9,615
-59% -$2.44M
CENX icon
245
Century Aluminum
CENX
$4.43B
$1.56M 0.08%
+85,530
New +$1.68M
GKOS icon
246
Glaukos
GKOS
$9.83B
$1.54M 0.08%
10,281
-51,702
-83% -$7.12M
TXRH icon
247
Texas Roadhouse
TXRH
$13.5B
$1.54M 0.08%
8,524
-19,986
-70% -$3.76M
RVMD icon
248
Revolution Medicines
RVMD
$39.9B
$1.52M 0.08%
34,790
-18,571
-35% -$937K
TTI icon
249
TETRA Technologies
TTI
$1.14B
$1.5M 0.08%
418,059
+218,059
+109% +$775K
PH icon
250
Parker-Hannifin
PH
$123B
$1.49M 0.08%
2,347
+239
+11% +$158K

Similar funds

Cinctive Capital Management's Q4 2024 Portfolio in Review

As of Q4 2024, Cinctive Capital Management held 518 positions worth $1.97B, up 7.1% from $1.83B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Cinctive Capital Management deployed $90.9M of net new capital in Q4 2024, opening 156 new positions and adding to 91 existing holdings. Its largest new stake was Williams Companies: 680,125 shares worth $36.8M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 19% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Vistra, an estimated $18.9M trimmed.

  • Cinctive Capital Management's largest Q4 2024 buy was Williams Companies: 680,125 shares worth $36.8M.
  • Cinctive Capital Management added most to Constellation Energy in Q4 2024, an estimated $37.7M increase.
  • Cinctive Capital Management's biggest Q4 2024 reduction was Vistra, cutting an estimated $18.9M.
  • Cinctive Capital Management fully exited Stericycle Inc in Q4 2024, selling an estimated $25.6M.
  • Cinctive Capital Management's ten largest holdings make up 18% of its $1.97B portfolio in Q4 2024.
  • Cinctive Capital Management opened 156 new positions and closed 176 in Q4 2024.
  • Cinctive Capital Management's portfolio value rose 7.1% quarter-over-quarter to $1.97B.

Based on Cinctive Capital Management's 13F filing for Q4 2024, filed 12 Feb 2025.